EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ALS-related proteinopathies: From TDP-43 to mitochondrial proteinopathies

Emmanuelle C Genin, Véronique Paquis-Flucklinger

Current Opinion in Neurobiology · 2026

DOI: 10.1016/j.conb.2025.103163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Neurobiology, 2026. Verfasst von Emmanuelle C Genin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur (UniCA), Inserm U1081, CNRS UMR7284, Institute for Research on Cancer and Aging, Nice (IRCAN), Team «Mitochondria, diseases an…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Mitochondria, Mitochondrial Proteins, TDP-43 Proteinopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the progressive loss of motor neurons. ALS often overlaps clinically and pathologically with frontotemporal dementia (FTD), the second most common form of dementia. Like many neurodegenerative disorders, both ALS and FTD share a crucial pathological hallmark, the aggregation of misfolded proteins into insoluble inclusions in degenerating neurons. This process is referred to as proteinopathy. This review focuses on the proteinopathies associated with ALS, including aggregates of TDP-43, SOD1, FUS, and CHCHD10, which disrupt critical cellular processes such as RNA metabolism, mitochondrial function, and protein homeostasis. The review highlights to the identification of new types of mitochondrial and cytosolic aggregates linked to CHCHD10-related ALS. Although the precise pathological mechanisms remain to be fully elucidated, strategies aimed at restoring proteostasis and reducing protein aggregation may be promising therapeutic approaches for treating ALS, as they directly target fundamental pathogenic mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMitochondriaMitochondrial ProteinsTDP-43 ProteinopathiesMitochondrial DiseasesHumansAnimalsSuperoxide Dismutase-1RNA-Binding Protein FUSDNA-Binding Proteins

Substanzen

Mitochondrial ProteinsCHCHD10 protein, humanSuperoxide Dismutase-1RNA-Binding Protein FUSTARDBP protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Université Côte d'Azur (UniCA), Inserm U1081, CNRS UMR7284, Institute for Research on Cancer and Aging, Nice (IRCAN), Team «Mitochondria, diseases and Aging», Nice, France. Electronic address: emmanuelle.genin@univ-cote…
  • Université Côte d'Azur (UniCA), Inserm U1081, CNRS UMR7284, Institute for Research on Cancer and Aging, Nice (IRCAN), Team «Mitochondria, diseases and Aging», Nice, France; Department of Medical Genetics & Reference Cen…

Förderung

  • Foundation for Medical Research

Zitieren

APA

Genin, E. C., & Paquis-Flucklinger, V. (2026). ALS-related proteinopathies: From TDP-43 to mitochondrial proteinopathies. Current Opinion in Neurobiology. https://doi.org/10.1016/j.conb.2025.103163

Vancouver

Genin EC, Paquis-Flucklinger V. ALS-related proteinopathies: From TDP-43 to mitochondrial proteinopathies. Current Opinion in Neurobiology. 2026. doi:10.1016/j.conb.2025.103163

BibTeX
@article{Genin2026,
  author = {Genin, Emmanuelle C and Paquis-Flucklinger, Véronique},
  title = {ALS-related proteinopathies: From TDP-43 to mitochondrial proteinopathies},
  journal = {Current Opinion in Neurobiology},
  year = {2026},
  doi = {10.1016/j.conb.2025.103163}
}
Kostenlos starten →